Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy...

por Kim, Brian S., Silverberg, Jonathan I., Ständer, Sonja, Yosipovitch, Gil, Simpson, Eric L., DiBonaventura, Marco, Kerkmann, Urs, Farooqui, Saleem A., Biswas, Pinaki, Valdez, Hernan, Cameron, Michael C.
Publicado 2021

Tapinarof Cream 1% Once Daily for the Treatment of Plaque Psoriasis: Case Photography of Clinical Outcomes from Three Phase 3 Trials

por Desai, Seemal R., Stein Gold, Linda, Cameron, Michael C., Golant, Alexandra, Lewitt, G. Michael, Bruno, Matthew J., Martin, George, Brown, Philip M., Rubenstein, David S., Butners, Victoria, Tallman, Anna M.
Publicado 2023

Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III...

por Ständer, Sonja, Kwatra, Shawn G., Silverberg, Jonathan I., Simpson, Eric L., Thyssen, Jacob P., Yosipovitch, Gil, Zhang, Fan, Cameron, Michael C., Cella, Ricardo Rojo, Valdez, Hernan, DiBonaventura, Marco, Feeney, Claire
Publicado 2022

Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE

por Gooderham, Melinda J., Chu, Chia-Yu, Rojo, Ricardo, Valdez, Hernan, Biswas, Pinaki, Cameron, Michael C., Feeney, Claire, Encinas, Gerardo A., Peeples-Lamirande, Kathleen, Cappelleri, Joseph C., Myers, Daniela E., DiBonaventura, Marco
Publicado 2021